|OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
|08/08/18||OraSure Announces 2018 Second Quarter Financial Results|
|BETHLEHEM, Pa., Aug. 08, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the three and six months ended June 30, 2018.
Consolidated net revenues for the second quarter of 2018 were $43.6 million, a 9% increase from the second quarter of 2017. Consolidated net product revenues were $38.8 million, representing a 1% dec... |
|07/23/18||OraSure Technologies, Inc. Appoints Vice President, Corporate Communications|
|BETHLEHEM, Pa., July 23, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostics and specimen collection devices, today announced that Jeanne Mell has been appointed as the Company’s new Vice President, Corporate Communications. Ms. Mell will join OraSure on August 13, 2018.
Most recently, Ms. Mell served as Vice President Marketing Communications at the University City Science Center in Philadelphia, where she was responsible for corporate m... |
|07/19/18||OraSure Technologies Earnings Conference Call Invitation|
|2018 Second Quarter Earnings Conference Call Wednesday, August 8, 2018, 5:00 p.m. ET
BETHLEHEM, Pa., July 19, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2018 second quarter financial results, 2018 third quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, August 8, 2018.
August 8, 2018 Schedule
4:00 p.m. ET
2018 second quarter financial resul... |
|05/30/18||OraSure Technologies to Present at Jefferies Global Healthcare Conference|
|BETHLEHEM, Pa., May 30, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Stephen S. Tang, President and CEO, will speak to the investment community at Jefferies Global Healthcare Conference. The conference will be simultaneously webcast over the Internet.
Dr. Tang is scheduled to speak on June 6, 2018, at approximately 11:00 AM Eastern Time (8:00 AM Pacific Time). Interested inv... |
|There are currently no events scheduled.|